Navigation Links
Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
Date:11/1/2007

come, net 10,995 5,635 38,057 16,037

Interest expense (2,434) (2,478) (7,696) (7,934)

Other income - 3,403 - 3,403

Net loss $(1,693) $(13,717) $(26,152) $(52,225)

Amounts per common share:

Net loss per share, basic and

diluted $(0.01) $(0.04) $(0.08) $(0.17)

Weighted average shares, basic and

diluted 318,871 314,228 317,591 313,132

Note 1: In accordance with SFAS 123R, stock-based compensation expense is allocated between research and development and selling, general and administrative expense as follows:

Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006

Research and development $3,090 $5,603 $8,235 $17,935

Selling, general and

administrative 3,792 4,642 10,748 14,291

Millennium Pharmaceuticals, Inc.

Reconciliation of GAAP to Non-GAAP

(unaudited)

(in thousands, except per share amounts)

Three Months Ended September 30, 2007

Costs and Expenses

Net Income

(Loss)per

Share, Basic

Research and Selling, General Net Income and

Development and Administrative (Loss) Diluted

GAAP $72,551 $42,949 $(1,69
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/29/2015)... 2015 As a symbol of its ... our pharmaceutical manufacturing clients, Whitehouse Laboratories is excited to ... Berkenstock Race Team for the 2015 race season. Success ... but a strong sense of precision and attention to ... success in the quality control testing laboratory. Sponsorship of ...
(Date:3/27/2015)... March 27, 2015 The consumption of ... of the recession and high prices in 2008. However, ... recovered and keeps on gaining momentum now. , To ... at more than 100,000 thousand tonnes. No considerable growth ... the global capacity rocketed during 2012-2013, registering 11% growth ...
(Date:3/27/2015)... 27, 2015  Neogen Corporation (NASDAQ: NEOG ) ... prearranged trading plan in accordance with Securities and Exchange ... CEO of Neogen Corporation, is a minority owner of ... stock. Herbert does not have control of ... filing is only for a portion of the shares ...
Breaking Biology Technology:Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 2World NPK Fertilizers Market Keeps On Gaining Momentum, According to BAC Reports Study Available at MarketPublishers.com 3Neogen CEO adopts 10b5-1 Trading Plan 2
... ... Cardiovascular Drug, CALGARY, June ... to developing a portfolio of,therapeutic proteins for metabolic and cardiovascular ... (safflower Apo AI(Milano)) is functional in a widely accepted,animal model. ...
... 5 Anesiva,Inc. (Nasdaq: ANSV ) today ... its NF-kappa B Decoy (NF-kB Decoy) program, which ... Therapeutics,Inc. (TFT). NF-kB Transcription Factor Decoy inhibits NF-kappa ... diseases such as inflammatory,bowel disease (IBD), eczema, rheumatoid ...
... Shuji Nakamura, Director UC Santa Barbara,s Solid-State Lighting and ... 2008 Prince of Asturias Award for Technical and Scientific ... with a medal and a Joan Miro sculpture commissioned ... also share a 50,000 (US$77,000) stipend. , The Technical ...
Cached Biology Technology:SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 2SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 3SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano) 4Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 2Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program 3
(Date:3/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, announces its biometric payment technology, the Wocket® smart ... starting March 30 th . The ... New York markets. Gino ... our new ad campaign following the recent initial shipment of ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has ... Strategic Business Report" report to their offering. ... US$ Thousands. The report provides separate comprehensive analytics for the ... , Europe , Asia-Pacific ... Latin America . Annual estimates and forecasts ...
(Date:3/17/2015)... , March 17, 2015 Emotient, the ... software, today announced general availability of Emotient ... for the analysis of facial expressions. The system ... media content, products and services. It delivers audience ... and sentiment - as derived from facial evidence ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... blockers were first used clinically, scientists can finally get ... beta2-adrenergic receptor. This receptor hails from a family of ... bodily functions, several of our senses, and the action ... the first known structure of a human GPCR, the ...
... study concludes that increasing levels of ozone due to ... vegetation, resulting in serious costs to the world,s economy. ... of Energy Policy, focused on how three environmental changes ... human activity will affect crops, pastures, and forests. ...
... South East Asia with the official launch of SCI ... 27th November 2007. Followed by detailed research ... markets worldwide, with overwhelming support and enthusiasm towards SCIs ... SCI India will offer its membership the opportunity to ...
Cached Biology News:Scientists unveil structure of molecular target of many drugs 2MIT: Human-generated ozone will damage crops 2MIT: Human-generated ozone will damage crops 3SCI marks expansion into Asia with the launch of SCI INDIA 2
... Compound(s) tested through 63 ... assays spanning a broad ... panel includes many non ... several non-selective assays. ...
...
... The Genome Sequencer 20 System revolutionizes ... massively parallel fashion. The Genome Sequencer ... accessories Reagents and consumables for library ... for mapping and de novo assembly ...
... to the maintenance of appropriate levels ... important and diverse as those involved ... stress response, antigen presentation, modulation of ... cell cycle regulation, transcription, and signalling ...
Biology Products: